BTCY — BIOTRICITY INC.
—
OTC ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1630113 ·
Last close
$0.07
Market Cap
$1.39M
52W High
$0.75
52W Low
$0.06
ADV30
23,562
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 4,276,956 | 3,530,820 | 158,068 | -959,468 | 6,023,510 | 466,503 | 39,715,894 |
| Mar 2026 | 4,250,632 | 3,399,024 | 694,557 | -324,182 | 6,446,488 | 149,789 | 39,408,954 |
| Dec 2025 | 3,987,819 | 3,251,476 | 440,915 | -717,067 | 5,686,495 | 256,357 | 38,208,764 |
| Sep 2025 | 3,885,795 | 3,181,498 | 273,819 | -690,913 | 6,322,772 | 308,460 | 37,984,860 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-718,955
Investing CF
$0
Financing CF
$557,736
CapEx
—
Dividends Paid
$-24,033
Buybacks
$0
EPS Diluted TTM
$-0.15
As of
2026-08-23
Balance + Analyst (yfinance extras)
Retained Earnings
$-142,570,243
Inventory
$1,341,295
Receivables
$4,365,400
ST Investments
—
EBIT TTM
$1,703,707
Pretax Income TTM
$-2,404,139
Interest Exp TTM
$4,107,846
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$16,401,202
EBITDA
$1,573,312
Free Cash Flow
$2,358,430
Enterprise Value
$32,713,590
Total Cash
$1,773,304
Total Debt
$26,929,796
Shares Out
19,914,003
Trailing EPS
$-0.13
Book Value
$-1.87
ROE
—
ROA
16.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 15,998,239 | 1,691,236 | -2,404,139 | 6,446,488 | 39,408,954 | -32,962,466 | -718,955 |
| Mar 2025 | 13,790,294 | -2,448,966 | -8,421,179 | 5,640,954 | 35,655,054 | -30,014,100 | -2,380,177 |
| Mar 2024 | 12,063,345 | -8,828,269 | -14,094,283 | 5,942,625 | 35,919,442 | -29,976,817 | -6,693,912 |
| Mar 2023 | 9,639,057 | -15,409,711 | -18,658,143 | 6,510,544 | 26,355,929 | -19,845,385 | -13,547,935 |
| Mar 2022 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.43
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BBLG | Bone Biologics Corp | $1.37M | $0.50 | — |
| GCTK | Glucotrack, Inc. | $1.44M | $1.80 | — |
| ESMC | ESCALON MEDICAL CORP | $1.26M | $0.17 | — |
| NUMD | Nu-Med Plus, Inc. | $1.22M | $0.01 | — |
| ALUR | ALLURION TECHNOLOGIES, INC. | $1.13M | $1.13 | — |
News headlines (Yahoo Finance, 1h cache)
Biotricity, Inc to Present at the LD Micro Invitational XVI
2026-05-12 12:15 · Yahoo
Q2 Investor Summit Virtual Live Wednesday June 24
2026-06-23 19:40 · Yahoo
Biotricity Inc (BTCY) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic AI ...
2026-02-12 05:02 · Yahoo
Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA
2026-02-11 21:00 · Yahoo
Biotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th
2026-02-05 21:15 · Yahoo
The Zacks Analyst Blog Highlights Hims & Hers Health, Biotricity and Privia Health
2025-12-24 14:58 · Yahoo
3 Healthcare IT Stocks Up More Than 20% in 2025 With More Room to Run
2025-12-23 19:08 · Yahoo
Biotricity Strengthens Path to Scalable Profitability with Sustained Margins & Operational Efficiency in Second Quarter Fiscal 2026
2025-11-14 21:00 · Yahoo
Fate Therapeutics (FATE) Reports Q3 Loss, Beats Revenue Estimates
2025-11-13 14:40 · Yahoo
Pulmonx Corporation (LUNG) Reports Q3 Loss, Beats Revenue Estimates
2025-11-12 22:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.